CDH1 and pancreatic neoplasm: However, in many invasive cancers, including pancreatic cancer, E-cadherin expression is often retained (David and Rajasekaran, 2012, Shamir et al., 2014) and utilized positively during cancer progression (Campbell and Casanova, 2015, Wicki et al., 2006).